IRIS Int'l. (IRIS) Subsidiary Requests Regulatory Clearance from U.S. FDA for NADiA ProsVue
Tweet Send to a Friend
IRIS International, Inc. (Nasdaq: IRIS) announced today that its IRIS Molecular Diagnostics (IMD) subsidiary has submitted a 510(k) pre-market notification ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
